RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is marking its tenth anniversary this year – placing it at the center of the journey from fledging concept to a fully realized, evidence-based methodology. The organization was just a year old when the US Food and Drug Administration (FDA) first recommended […]
Federated Learning & Risk-Based Data Management – The Future of Smart Healthcare
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the application of machine learning (ML) in healthcare and clinical research.” Federated Learning (FL) is a method used for training Machine Learning models. It can decentralize the training process by providing access to data from multiple disparate sources without directly sharing […]
CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities. The category recognizes the efforts of an individual, team, or company for innovative work in developing new treatments, […]
CluePoints Continues Impressive Global Growth with Three New Senior Appointments
King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations. Catherine brings more than a decade of experience in the life science industry as a creative and insightful […]
UK Regulator Cites CluePoints’ Solutions in Updated Guidance
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s considerable weight behind CluePoints’ industry-leading statistical monitoring solutions. The document, Oversight and Monitoring Activities, covers a broad range of […]
CluePoints Senior Vice President, Europe, and APAC, to Speak at SCOPE 2022
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful decentralized trials at this year’s SCOPE Conference, a Summit for Clinical Ops Executives. Delivering Successful Decentralized Trials – How RBQM and Centralized Monitoring can Maximize Data Quality will occur at 12:30 pm on February 8, 2022. The shift to decentralized research […]
HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to provide Risk-Based Quality Management (RBQM) expertise and technology in the Chinese region. This market-leading partnership will increase clinical trial efficiency and reduce deviation and […]
CluePoints Wins Scrip Award for Clinical Advance of the Year 2021
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category – COVID-19 Pandemic Special Recognition Award at the 17th Annual Scrip Awards. The 2021 Scrip Awards was held at the Royal Lancaster Hotel, London, […]
CluePoints Chief Scientific Officer to Speak at CNS Summit Next Month
Steve Young, Chief Scientific Officer at CluePoints, will take to the podium at this year’s CNS Summit with Lynne Cesario, Global Risk-Based Monitoring Program Lead at Pfizer. The Patients are Waiting – Reducing 10 Years of Development to Less Than 10 Months takes place on the second day of the summit (Monday, November 8). Held from […]
CluePoints SVP of Business Development to Speak at Clinical Trials Europe
John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated with Decentralized Clinical Trials (DCTs) at Clinical Trials Europe. The Dimensions of Risk Associated with DCT’s is a Spotlight Session on day 2 of the virtual summit. From 1.35 pm on 3 November, John will share his expertise on the […]
